SELPLG and Thrombocytopenia: Attenuation of thrombocytopenia by inhibiting platelet aggregation, depleting F508del neutrophils, blocking PSGL-1 or PAF, or rectifying of F508del CFTR trafficking in LPS-challenged F508del mice significantly diminished neutrophil transalveolar migration or lung inflammation.